A Study of Medication With or Without Psychotherapy for Complicated Grief
Completed · Phase 2 · Has a placebo group
Conditions studied: Complicated Grief, Bereavement
In brief
The major goal of this 4-site, double blind, placebo-controlled intervention trial is to assess the efficacy of medication (Citalopram) alone or with psychotherapy (Complicated Grief Therapy) to treat the symptoms of complicated grief.
Key facts
- Study ID
- NCT01179568
- Run by
- New York State Psychiatric Institute
- People needed
- 395
- Starts
- 2010-03-01
- Expected to finish
- 2015-07-01
- Last updated by the study team
- 2017-01-24
Who can join
Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with Complicated Grief and this is the patient's most important (primary) problem
- Ability to give informed consent
- Fluent in English
- Willingness to have sessions audiotaped
- Willingness to undergo random assignment
You may not qualify if…
- Diagnosis of one or more of the following disorders: Schizophrenia or other psychotic disorder, current (past 6 months) substance abuse, Bipolar Disorder, current manic episode, Dementia
- Pregnant or lactating women and women of childbearing potential not using medically accepted forms of contraception
- Acute, unstable or severe medical illness such as (but not limited to) stroke, epilepsy, or other neurodegenerative disorders, metastatic or active cancer, hepatic disease, or primary renal disease requiring dialysis
- Prior intolerance of citalopram
- Pending or active disability claim or lawsuit related to the death
Where it is running
- VASDHS / University of California San Diego — San Diego, California, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- New York State Psychiatric Institute — New York, New York, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.